Moin Makda Presented ThalSaarthi with Attempt to Solve HbA2 Borderline Specific Problem
Moin Makda, AI Developer at Fortis Memorial Research Institute, posted on LinkedIn:
“”Is it normal or is it trait?”
A question asked thousands of times daily across India. HbA2 borderline. Traditional algorithms say inconclusive, patient waits days for expert opinion.
At Haematocon 2025, I presented ThalSaarthi with our attempt to solve this specific problem.
Every 35 minutes, a child is born with thalassemia major in India. Over 40 million carriers exist, but 70% of our population lacks access to expert hemoglobinopathy screening. The gap between disease burden and diagnostic capacity is staggering.
We built something different. An AI system that brings expert level hemoglobinopathy interpretation to district hospitals and mobile screening camps where it’s needed most. The goal isn’t to replace hematologists but to extend their reach.
What makes it different:
-> Works completely offline (privacy preserving, no cloud dependency)
-> Resolves the ambiguous, borderline cases that traditional algorithms fail on
-> Built specifically for resource constrained environments
The technical innovation: combining rule-based clinical logic with RAG + AI reasoning. Fast for clear cases. Intelligent for complex ones.
This isn’t about technology for technology’s sake. It’s about health equity. It’s about reaching the 70% who currently have less access. It’s about prevention at scale.
Deeply grateful to my mentors and team: Dr. Rahul Bhargava, Shrinidhi Nathany Swarsat K. Nath Dr. Kamlesh Prajapati
When expertise is scarce, intelligence must scale.”
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial
-
Feb 23, 2026, 11:37Charles Okyere Boadu: Blood Donation Helps Lower Your Risk of Stroke and Organ Damage